
Biomedical Technology, Год журнала: 2024, Номер 9, С. 100068 - 100068
Опубликована: Дек. 25, 2024
Язык: Английский
Biomedical Technology, Год журнала: 2024, Номер 9, С. 100068 - 100068
Опубликована: Дек. 25, 2024
Язык: Английский
Journal of Drug Delivery Science and Technology, Год журнала: 2025, Номер unknown, С. 106705 - 106705
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Pharmaceutics, Год журнала: 2025, Номер 17(3), С. 296 - 296
Опубликована: Фев. 24, 2025
Melanoma, a highly aggressive form of skin cancer, poses major therapeutic challenge due to its metastatic potential, resistance conventional therapies, and the complexity tumor microenvironment (TME). Materials science nanotechnology advances have led using nanocarriers such as liposomes, dendrimers, polymeric nanoparticles, metallic nanoparticles transformative solutions for precision melanoma therapy. This review summarizes findings from Web Science, PubMed, EMBASE, Scopus, Google Scholar highlights role in overcoming treatment barriers. Nanoparticles facilitate passive active targeting through mechanisms enhanced permeability retention (EPR) effect functionalization with tumor-specific ligands, thereby improving accuracy drug delivery reducing systemic toxicity. Stimuli-responsive systems multi-stage further improve overcome challenges poor penetration resistance. Emerging platforms combine diagnostic imaging delivery, paving way personalized medicine. However, there are still issues scalability, biocompatibility, regulatory compliance. comprehensive potential integrating genetics proteomics, scalable, patient-specific therapies. These interdisciplinary innovations promise redefine provide safer, more effective, accessible treatments. Continued research is essential bridge gap between evidence-based scientific clinical applications.
Язык: Английский
Процитировано
0Open Journal of Regenerative Medicine, Год журнала: 2025, Номер 14(01), С. 1 - 18
Опубликована: Янв. 1, 2025
Язык: Английский
Процитировано
0Nanomedicine, Год журнала: 2024, Номер unknown, С. 1 - 24
Опубликована: Ноя. 14, 2024
Conventional cancer therapy has major limitations, including non-specificity, unavoidable side effects, low specific tumor accumulation and systemic toxicity. In recent years, more effective precise treatment methods have been developed, cell-based immunotherapy. Carriers that can accurately specifically target cells equip them to combat are particularly important for developing this therapy. As a result, attention drawn smart nanocarriers react stimuli. Thus, stimuli-responsive attracted increasing because they change their physicochemical properties in response stimulus conditions, such as pH, enzymes, redox agents, hypoxia, light temperature. This review highlights advances various nanocarriers, discussing loading, targeted delivery, cellular uptake, biocompatibility immunomodulation Finally, future challenges perspectives regarding the possible clinical translation of discussed.
Язык: Английский
Процитировано
1Biomedical Technology, Год журнала: 2024, Номер 9, С. 100068 - 100068
Опубликована: Дек. 25, 2024
Язык: Английский
Процитировано
1